Home › Idiopathic Pulmonary Fibrosis › Georgia
Idiopathic Pulmonary Fibrosis clinical trials in Georgia
5 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Georgia.
Cities in Georgia
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Piedmont Healthcare, Inc., Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Atlanta
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Emory University, Atlanta
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Emory University, Atlanta
- Piedmont Healthcare, Austell
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Atlanta, GA, Atlanta
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.